News AI health tech Respiree closes $11.6m Series A Health tech Respiree, developer of AI platforms to manage disease progression, has announced the successful closing of an $11.6m Series A financing.
Home 1000Farmacie Secures $25 Million in Series A Funding The Healthware Ventures portfolio company 1000Farmacie, a leading Italian e-pharmacy marketplace, has announced the successful completion of its second tranche of Series A
News Maxion Therapeutics gets $16m Series A Financing LifeArc Ventures leads $16m Series A of Maxion Therapeutics for antibody development overhaul.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face